Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-24-166301
Filing Date
2024-06-24
Accepted
2024-06-24 07:27:26
Documents
3
Group Members
ALKALOIDA CHEMICAL CO ZRT (F/K/A ALKALOIDA CHEMICAL CO EXCLUSIVE GROUP LIMITED)DILIP S. SHANGHVISUN PHARMA HOLDINGSSUN PHARMACEUTICAL HOLDINGS USA, INC.SUN PHARMACEUTICAL INDUSTRIES, INC. (F/K/A CARACO PHARMACEUTICAL LABORATORIES, LTD.)TARO DEVELOPMENT CO

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d839297dsc13da.htm SC 13D/A 145919
2 EX-99.60 d839297dex9960.htm EX-99.60 7983
3 GRAPHIC g839297g0621202550514.jpg GRAPHIC 3261
  Complete submission text file 0001193125-24-166301.txt   160678
Mailing Address THREE SKYLINE DR HAWTHORNE NY 10532
Business Address 14 HAKTOR ST HAIFA BAY L3 26110 9143459001
TARO PHARMACEUTICAL INDUSTRIES LTD (Subject) CIK: 0000906338 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-49231 | Film No.: 241062059
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 17/B, MAHAL INDUSTRIAL ESTATE MAHAKALI CAVES ROAD ANDEHERI (EAST) K7 400 093
Business Address 17/B, MAHAL INDUSTRIAL ESTATE MAHAKALI CAVES ROAD ANDEHERI (EAST) K7 400 093 01191228212128
SUN PHARMACEUTICAL INDUSTRIES LTD (Filed by) CIK: 0001197089 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0331
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)